fasudil has been researched along with Hypospadias in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Hypospadias: A birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, S | 1 |
| Shi, F | 1 |
| Xie, Z | 1 |
| Wu, L | 1 |
| Dai, M | 1 |
| Zhang, Y | 1 |
| Xu, X | 1 |
| Zhu, Y | 1 |
| Jiang, J | 1 |
1 other study available for fasudil and Hypospadias
| Article | Year |
|---|---|
Di-n-butyl phthalate induces oversecretion of vascular endothelium-derived NAP-2 and promotes epithelial-mesenchymal transition of urothelial cells in newborn hypospadias rats.
Topics: Animals; Cytokines; Dibutyl Phthalate; Endothelium, Vascular; Epithelial-Mesenchymal Transition; Fem | 2023 |